Lowenstein Sandler represents Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a precision oncology company, in its exclusive licensing agreement with CSPC Megalith Biopharmaceutical Co., Ltd, a subsidiary of CSPC Pharmaceutical Group Limited...
Lowenstein Sandler and two of its trademark partners, Vanessa A. Ignacio and Matthew P. Hintz, are included in the 2023 edition of World Trademark Review 1000 – The World’s Leading Trademark Professionals (WTR 1000). This is the twelfth consecutiv...
Lowenstein Sandler represented Ladenburg Thalmann & Co. Inc., B. Riley Securities, Inc. and Roth Capital Partners, LLC in an At-The-Market sales agreement for the issuance of up to $100 million of common stock of Meta Materials Inc. (NASDAQ:MM...